EU approves fourth vaccine
----------------------------------
The European Union has approved Johnson & Johnson’s single-shot
Janssen vaccine* – J&J’s shot joins three other EU-approved vaccines from Pfizer-BioNTech, AstraZeneca-Oxford and Moderna
----------------------------------
Ursula von der Leyen

J&J single-shot vaccine
In large-scale study, vaccine was 72% protective in U.S., 66% in South America, and 57% in South Africa – where new variant has spread

EU Commission President: J&J shot will enable EU to vaccinate 200 million people

Efficacy of other EU-approved vaccines
----------------------------------
Vaccines require two shots
----------------------------------
Pfizer-BioNTech
First dose: 62% protection
Second dose: 92.6% protection
Interval: 21 days apart
----------------------------------
AstraZeneca-Oxford
First dose: 76%
Second dose:  82.4%
Interval: 8-12 weeks
----------------------------------
Moderna  vaccine
First dose: 92.1%
Second dose: 94.1% 
Interval: 28 days
----------------------------------
*Made by Johnson & Johnson’s Janssen Pharmaceuticals in Belgium
----------------------------------
Source: BMJ, Financial Times, Healthline Picture: Associated Press © GRAPHIC NEWS


words:142